Sean A. McCarthy insider trades
Open-market stock purchases and sales by Sean A. McCarthy, CEO at CytomX Therapeutics, Inc, from SEC Form 4 filings since Jan 21, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 17, 2026 | CTMX CytomX Therapeutics, Inc | Sold | $764K |
| Feb 2, 2026 | CTMX CytomX Therapeutics, Inc | Bought (not open market) | — |
| Feb 2, 2026 | CTMX CytomX Therapeutics, Inc | Bought (not open market) | — |
| Nov 6, 2025 | CTMX CytomX Therapeutics, Inc | Sold | $462K |
| Nov 6, 2025 | CTMX CytomX Therapeutics, Inc | Sold | $462K |
| Nov 6, 2025 | CTMX CytomX Therapeutics, Inc | Bought (not open market) | $162K |
| Nov 6, 2025 | CTMX CytomX Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CTMX CytomX Therapeutics, Inc: 46 sales, last Mar 17, 2026